Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials

BACKGROUND: The nucleotide analogue prodrug remdesivir was among the first antiviral therapies to be tested in randomized controlled trials (RCTs) for COVID-19. We performed a meta-analysis to understand efficacy and safety. METHODS: We searched PubMed, EMBASE, Cochrane library, and ClinicalTrials.g...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Abdouh, Ahmad, Bizanti, Anas, Barbarawi, Mahmoud, Jabri, Ahmad, Kumar, Ashish, Fashanu, Oluwaseun E., Khan, Safi U., Zhao, Di, Antar, Annukka A.R., Michos, Erin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789823/
https://www.ncbi.nlm.nih.gov/pubmed/33422642
http://dx.doi.org/10.1016/j.cct.2021.106272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789823/
https://www.ncbi.nlm.nih.gov/pubmed/33422642
http://dx.doi.org/10.1016/j.cct.2021.106272

Ejemplares similares